FIELD: biotechnology.
SUBSTANCE: invention relates to mouse hybridoma AMACR with the registration number of VKPM N-166, which is a producer of a monoclonal antibody detecting the human cytoplasmic alpha-methylacyl coenzyme A racemase AMACR in adenocarcinoma cells of the prostate and in cells of other organs containing this antigen.
EFFECT: invention allows to obtain efficiently antibodies specifically detecting alpha-methylacyl coenzyme A racemase of human immunocytochemistry, immunohistochemistry, immunoblotting, and immunofluorescence.
4 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MURINE HYBRIDOMA YKL-40, CLONE 2G8 C10 - PRODUCER OF MONOCLONAL ANTIBODY POSSESSING SPECIFICITY TO CYTOPLASMIC ANTIGENS YKL-39, YKL-40 AND SI-CLP OF HUMAN | 2019 |
|
RU2728228C1 |
| MOUSE HYBRIDOMA PU.1, CLONE 4G6 - PRODUCER OF A MONOCLONAL ANTIBODY WITH SPECIFICITY TO THE HUMAN PU.1 PROTEIN | 2022 |
|
RU2788714C1 |
| MOUSE HYBRIDOMA SI-CLP, CLONE 3D4 - PRODUCER OF MONOCLONAL ANTIBODY POSSESSING SI-CLP PROTEIN SPECIFICITY | 2019 |
|
RU2714685C1 |
| MOUSE HYBRIDOMA YKL-39, CLONE 1B2 G4 IS PRODUCER OF A MONOCLONAL ANTIBODY HAVING SPECIFICITY FOR CYTOPLASMIC ANTIGEN YKL-39 | 2017 |
|
RU2667423C1 |
| MOUSE HYBRIDOMA 56 - PRODUCER OF MONOCLONAL ANTIBODY SHOWING SPECIFICITY TO CORE ANTIGEN OF HUMAN PROLIFERATING PCNA CELLS | 2010 |
|
RU2435850C1 |
| STRAIN OF CULTURED CELLS OF MURINE HYBRIDOMA A3 USED FOR OBTAINING MONOCLONAL ANTIBODIES AGAINST HUMAN CELL NUCLEOLUS ANTIGEN | 2005 |
|
RU2296159C2 |
| MOUSE HYBRIDONE S148-PRODUCER OF MONOCLONAL ANTIBODY TO NUCLEOLAR PROTEIN SURF-6 OF MAMMALS | 2010 |
|
RU2421514C1 |
| MOUSE HYBRIDOMA S79 - PRODUCER OF MONOCLONAL ANTIBODY SHOWING SPECIFICITY TO HUMAN NUCLEOLUS PROTEIN SURF-6 | 2010 |
|
RU2422516C1 |
| PSCA-CAR-YT CELL LINE HAVING SURFACE EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS AND EXHIBITING CYTOTOXIC ACTIVITY ON PSCA-POSITIVE HUMAN CANCER CELLS | 2018 |
|
RU2712901C1 |
| METHOD OF DETERMINING THE RISK OF MALIGNANT TRANSFORMATION OF PROSTATE CELLS | 2022 |
|
RU2806518C1 |
